
  
    
      
        Introduction_NNP
        The_DT liver_NN exclusively_RB synthesizes_NNS bile_NN acids_NNS from_IN
        cholesterol_NN via_IN two_CD biosynthetic_JJ pathways_NNS ._. The_DT "_'' classical_JJ "_''
        pathway_NN begins_VBZ with_IN the_DT 7_CD α-hydroxylation_JJ of_IN cholesterol_NN and_CC
        operates_VBZ entirely_RB in_IN the_DT liver_NN [_NN 1_CD ]_NN ._. The_DT "_'' alternative_NN "_''
        pathway_NN begins_VBZ with_IN the_DT hydroxylation_NN of_IN the_DT cholesterol_NN
        side_NN chain_NN ._. Although_IN this_DT reaction_NN occurs_VBZ in_IN a_DT wide_JJ variety_NN
        of_IN cells_NNS ,_, the_DT completion_NN of_IN bile_NN acid_NN synthesis_NN takes_VBZ place_NN
        in_IN liver_NN cells_NNS ._. The_DT classical_JJ pathway_NN is_VBZ responsible_JJ for_IN
        the_DT bulk_NN of_IN the_DT bile_NN acids_NNS synthesized_JJ by_IN the_DT liver_NN [_NN 2_CD 3_CD ]_NN
        ._.
        The_DT major_JJ bile_NN acid_NN species_NNS produced_VBN by_IN the_DT liver_NN are_VBP
        cholic_JJ and_CC chenodeoxycholic_JJ acids_NNS ._. These_DT bile_NN acids_NNS are_VBP
        conjugated_JJ to_TO either_CC taurine_NN or_CC glycine_NN before_IN secretion_NN
        into_IN bile_NN [_NN 4_CD ]_NN ,_, which_WDT is_VBZ subsequently_RB released_VBN into_IN the_DT
        small_JJ intestine_NN ._. Bile_NNP acids_NNS are_VBP reclaimed_VBN from_IN the_DT lumen_NN of_IN
        the_DT intestine_NN and_CC returned_VBD to_TO the_DT liver_NN via_IN portal_NN blood_NN
        for_IN reuse_NN [_NN 1_CD ]_NN ._. The_DT recovery_NN of_IN bile_NN acids_NNS from_IN the_DT
        intestine_NN is_VBZ an_DT efficient_JJ process_NN that_WDT involves_VBZ both_DT
        passive_JJ transport_NN along_IN the_DT entire_JJ axis_NNS of_IN the_DT intestine_NN ,_,
        and_CC active_JJ transport_NN in_IN the_DT terminal_NN ileum_NN [_NN 5_CD ]_NN ._. The_DT
        apical_JJ sodium_NN /_NN bile_NN acid_NN co-transporter_JJ (_( asbt_NN )_) mediates_NNS the_DT
        active_JJ uptake_NN of_IN conjugated_JJ bile_NN acids_NNS in_IN the_DT ileum_NN [_NN 5_CD 6_CD ]_NN
        ._. In_IN hepatocytes_NNS ,_, both_DT sodium-dependent_JJ and_CC
        sodium-independent_JJ transport_NN systems_NNS on_IN the_DT sinusoidal_NN
        membranes_NNS extract_VB bile_NN acids_NNS from_IN portal_NN blood_NN ._. Of_IN these_DT ,_,
        the_DT sodium_NN /_NN bile_NN acid_NN co-transporting_JJ polypeptide_NN (_( ntcp_NN )_) is_VBZ
        considered_VBN to_TO be_VB quantitatively_RB the_DT most_RBS important_JJ
        transporter_NN of_IN conjugated_JJ bile_NN acids_NNS in_IN these_DT cells_NNS [_NN 7_CD 8_CD ]_NN
        ._. The_DT transport_NN of_IN bile_NN acids_NNS from_IN the_DT basolateral_NN to_TO the_DT
        canalicular_NN membrane_NN of_IN liver_NN cells_NNS is_VBZ a_DT poorly_RB understood_VBN
        process_NN ._. Intracellular_NNP bile_NN acid_NN binding_JJ proteins_NNS have_VBP been_VBN
        postulated_JJ to_TO participate_VB in_IN the_DT transcellular_NN transport_NN as_RB
        well_RB as_IN to_TO buffer_VB against_IN the_DT cytotoxic_JJ effects_NNS of_IN bile_NN
        acids_NNS ._. ATP-dependent_NNP transporters_NNS on_IN the_DT canalicular_NN
        membranes_NNS of_IN hepatocytes_NNS mediate_VB the_DT secretion_NN of_IN bile_NN
        acids_NNS into_IN bile_NN [_NN 9_CD ]_NN ._.
        Recently_RB ,_, it_PRP was_VBD discovered_VBN that_IN bile_NN acids_NNS are_VBP the_DT
        natural_JJ ligands_NNS for_IN a_DT nuclear_JJ receptor_NN termed_VBD farnesoid_NN x_SYM
        receptor_NN (_( FXR_NNP ;_: NR_NNP 1_CD H_NNP 4_LS )_) [_NN 10_CD 11_CD 12_CD ]_NN ._. Therefore_RB ,_, bile_NN acids_NNS
        may_MD be_VB important_JJ regulators_NNS of_IN gene_NN expression_NN in_IN the_DT liver_NN
        and_CC intestines_NNS ._. To_TO date_NN ,_, the_DT genes_NNS that_WDT have_VBP been_VBN shown_VBN to_TO
        be_VB responsive_JJ to_TO regulation_NN by_IN FXR_NNP encode_NN proteins_NNS involved_VBN
        in_IN the_DT biosynthesis_NNS and_CC transport_NN of_IN bile_NN acids_NNS [_NN 13_CD ]_NN ._.
        Bile_NNP acids_NNS have_VBP been_VBN shown_VBN to_TO modulate_VBP a_DT variety_NN of_IN other_JJ
        cellular_JJ functions_NNS ,_, such_JJ as_IN secretion_NN of_IN lipoproteins_NNS from_IN
        hepatocytes_NNS [_NN 14_CD 15_CD ]_NN and_CC translocation_NN of_IN bile_NN acid_NN
        transporters_NNS to_TO the_DT hepatocyte_NN canalicular_NN membrane_NN [_NN 16_CD ]_NN
        ._. In_IN McNtcp_NNP cells_NNS ,_, which_WDT are_VBP liver-derived_JJ cells_NNS engineered_VBN
        to_TO transport_VB bile_NN acids_NNS actively_RB [_NN 17_CD ]_NN ,_,
        taurine-conjugated_JJ bile_NN acids_NNS induce_VB the_DT formation_NN of_IN
        intracellular_NN vesicles_NNS that_WDT resembles_VBZ structures_NNS observed_VBN
        in_IN cholestatic_JJ liver_NN cells_NNS without_IN apparent_JJ cellular_JJ
        cytotoxicity_NN [_NN 1_CD 18_CD ]_NN ._. In_IN contrast_NN ,_, glycine-conjugated_JJ
        bile_NN acids_NNS promote_VBP apoptosis_NNS in_IN these_DT cells_NNS [_NN 19_CD ]_NN ._. Thus_RB ,_,
        different_JJ classes_NNS of_IN conjugated_JJ bile_NN acids_NNS stimulate_VB
        distinctive_JJ responses_NNS in_IN McNtcp_NNP cells_NNS ._. Whereas_IN
        taurine-conjugated_JJ bile_NN acids_NNS are_VBP well_RB tolerated_JJ ,_,
        glycine-conjugated_JJ bile_NN acids_NNS are_VBP extremely_RB cytotoxic_JJ ._. Here_RB
        we_PRP examined_VBD if_IN this_DT differential_NN response_NN is_VBZ limited_VBN to_TO
        cells_NNS that_WDT normally_RB metabolize_NN bile_NN acids_NNS ,_, and_CC whether_IN high_JJ
        level_NN expression_NN of_IN an_DT intracellular_NN bile_NN acid_NN binding_JJ
        protein_NN can_MD attenuate_NN the_DT cytotoxic_JJ response_NN of_IN McNtcp_NNP ._. 24_CD
        cells_NNS to_TO glycine-conjugated_JJ bile_NN acids_NNS ._.
      
      
        Results_NNS
        
          Differential_NNP cytotoxicity_NN of_IN glycine-conjugated_JJ
          bile_NN acids_NNS in_IN McNtcp_NNP ._. 24_CD cells_NNS
          We_PRP previously_RB showed_VBD that_IN taurine-conjugated_JJ bile_NN
          acids_NNS ,_, such_JJ as_IN taurocholic_JJ (_( TCA_NNP )_) and_CC
          taurochenodeoxycholic_JJ (_( TCDCA_NNP )_) acids_NNS ,_, were_VBD well_RB tolerated_JJ
          by_IN McNtcp_NNP ._. 24_CD cells_NNS [_NN 18_CD ]_NN ._. In_IN contrast_NN ,_,
          glycine-conjugated_JJ bile_NN acids_NNS ,_, such_JJ as_IN glycocholic_JJ (_( GCA_NNP )_)
          and_CC glycochenodeoxycholic_JJ (_( GCDCA_NNP )_) acids_NNS ,_, were_VBD cytotoxic_JJ
          to_TO McNtcp_NNP ._. 24_CD cells_NNS [_NN 1_CD ]_NN concordant_NN with_IN what_WP has_VBZ been_VBN
          documented_VBN in_IN hepatocytes_NNS [_NN 19_CD ]_NN ._. Consistent_NNP with_IN the_DT
          induction_NN of_IN apoptotic_JJ cell_NN death_NN ;_: GCDCA_NNP ,_, but_CC not_RB TCA_NNP ,_,
          preferentially_RB induced_VBD the_DT activation_NN of_IN the_DT initiator_NN
          caspase_NN 8_CD in_IN McNtcp_NNP ._. 24_CD cells_NNS (_( Figure_NN 1_CD A_DT )_) ._. Indeed_RB ,_,
          glycine-conjugated_JJ bile_NN acids_NNS as_IN a_DT class_NN of_IN molecules_NNS
          induced_VBD genomic_JJ DNA_NNP fragmentation_NN in_IN this_DT cell_NN line_NN at_IN
          low_JJ concentrations_NNS (_( 50_CD μM_NN )_) ,_, while_IN their_PRP$ taurine_NN
          counterparts_NNS did_VBD not_RB (_( Figure_NN 1_CD B_NNP )_) ._. The_DT cytotoxicity_NN of_IN
          glycine-conjugated_JJ bile_NN acids_NNS cannot_NN be_VB attributed_VBN simply_RB
          to_TO the_DT preferential_JJ cellular_JJ accumulation_NN of_IN these_DT bile_NN
          acids_NNS because_IN McNtcp_NNP ._. 24_CD cells_NNS can_MD accumulate_VBP GCA_NNP and_CC TCA_NNP
          to_TO similar_JJ levels_NNS (_( Torchia_NNP and_CC Agellon_NNP ,_, unpublished_JJ
          observations_NNS )_) ._.
          There_EX is_VBZ considerable_JJ evidence_NN to_TO suggest_VB that_IN bile_NN
          acids_NNS activate_VBP a_DT variety_NN of_IN cellular_JJ signaling_VBG pathways_NNS
          in_IN liver_NN cells_NNS [_NN 20_CD ]_NN ._. TCDCA_NNP is_VBZ capable_JJ of_IN activating_VBG
          PI_NNP 3_CD K_NNP activity_NN in_IN McNtcp_NNP ._. 24_CD cells_NNS and_CC ,_, direct_JJ elevation_NN of_IN
          PI_NNP 3_CD K_NNP activity_NN by_IN transient_JJ expression_NN of_IN a_DT plasmid_NN
          encoding_VBG PI_NNP 3_CD K_NNP can_MD protect_VB McNtcp_NNP ._. 24_CD cells_NNS from_IN
          GCDCA-induced_NNP apoptosis_NNS [_NN 21_CD ]_NN ._. TCA_NNP ,_, like_IN TCDCA_NNP ,_, also_RB
          caused_VBD the_DT elevation_NN of_IN PI_NNP 3_CD K_NNP activity_NN in_IN McNtcp_NNP ._. 24_CD cells_NNS
          (_( Figure_NN 2_CD A_DT )_) ,_, suggesting_VBG that_DT activation_NN of_IN PI_NNP 3_CD K_NNP may_MD be_VB a_DT
          general_JJ response_NN to_TO taurine-conjugated_JJ bile_NN acids_NNS ._.
          Treatment_NNP of_IN McNtpc_NNP ._. 24_CD cells_NNS with_IN LY_NNP 294002_CD ,_, a_DT PI_NNP 3_CD K_NNP
          inhibitor_NN ,_, prior_RB to_TO the_DT addition_NN of_IN TCA_NNP or_CC TCDCA_NNP resulted_VBD
          in_IN the_DT loss_NN of_IN tolerance_NN to_TO these_DT bile_NN acids_NNS as_IN
          demonstrated_VBN by_IN the_DT activation_NN of_IN caspase_NN 8_CD (_( Figure_NN 2_CD B_NNP )_) ._.
          On_IN the_DT other_JJ hand_NN ,_, preincubation_NN of_IN McNtcp_NNP ._. 24_CD cells_NNS with_IN
          either_DT TCA_NNP or_CC TCDCA_NNP attenuated_JJ the_DT GCDCA-mediated_NNP
          activation_NN of_IN caspase_NN 8_CD (_( Figure_NN 2_CD C_NNP )_) ,_, suggesting_VBG that_IN the_DT
          activation_NN of_IN a_DT PI_NNP 3_CD K-_NNP dependent_JJ survival_NN pathway_NN is_VBZ
          dominant_JJ over_IN the_DT death_NN pathway_NN ._. These_DT results_NNS also_RB
          indicate_VBP that_IN the_DT differential_NN sensitivity_NN of_IN the_DT
          liver-derived_JJ McNtcp_NNP ._. 24_CD cells_NNS to_TO conjugated_JJ bile_NN acids_NNS is_VBZ
          due_JJ to_TO the_DT existence_NN of_IN a_DT specific_JJ mechanism_NN that_WDT is_VBZ
          capable_JJ of_IN recognizing_VBG different_JJ classes_NNS of_IN conjugated_JJ
          bile_NN acids_NNS ._. In_IN these_DT cells_NNS ,_, taurine-conjugated_JJ bile_NN acids_NNS
          specifically_RB increase_VBP PI_NNP 3_CD K_NNP activity_NN which_WDT ,_, in_IN turn_NN ,_, leads_VBZ
          to_TO the_DT activation_NN of_IN a_DT survival_NN pathway_NN [_NN 22_CD 23_CD ]_NN ._.
        
        
          Expression_NNP of_IN bile_NN acid_NN uptake_NN activity_NN in_IN CHO_NNP
          cells_NNS
          To_TO determine_VB if_IN non-liver_JJ derived_VBN cells_NNS also_RB posses_NNS
          differential_NN sensitivity_NN to_TO bile_NN acid-induced_JJ
          cytotoxicity_NN ,_, we_PRP engineered_VBN CHO_NNP cells_NNS to_TO take_VB up_RP bile_NN
          acids_NNS actively_RB by_IN expressing_VBG asbt_NN ._. Colonies_NNP surviving_VBG the_DT
          selection_NN process_NN were_VBD assayed_JJ for_IN asbt_NN activity_NN and_CC
          several_JJ clones_NNS showing_VBG a_DT range_NN of_IN bile_NN acid_NN uptake_NN
          activities_NNS were_VBD selected_VBN for_IN further_JJ analysis_NN ._. Analysis_NNP
          of_IN total_JJ RNA_NNP from_IN the_DT selected_VBN clones_NNS (_( CHO_NNP ._. asbt_NN )_) readily_RB
          showed_VBD the_DT presence_NN of_IN the_DT recombinant_JJ asbt_NN mRNA_NN (_( Figure_NN
          3_CD A_DT )_) ._. Correspondingly_NNP ,_, in_IN CHO_NNP ._. asbt_NN lysates_NNS ,_, an_DT
          immunoreactive_JJ band_NN of_IN comparable_JJ size_NN (_( ~_NN 45_CD kDa_NN )_) to_TO rat_VB
          asbt_NN protein_NN can_MD be_VB easily_RB detected_VBN using_VBG an_DT anti-asbt_JJ
          antibody_NN (_( Figure_NN 3_CD B_NNP )_) ._. The_DT uptake_NN of_IN bile_NN acids_NNS by_IN the_DT
          CHO_NNP ._. asbt_NN cells_NNS was_VBD saturable_JJ with_IN an_DT apparent_JJ K_NNP 
          m_NN ranging_VBG between_IN 22_CD to_TO 25_CD μM_NN (_( Figure_NN
          3_CD C_NNP )_) ._. The_DT V_NNP 
          max_NN values_NNS ranged_VBD from_IN 0_CD ._. 323_CD to_TO 2_CD ._. 769_CD
          nmol_NN /_NN mg_NN protein_NN /_NN min_NN and_CC correlated_JJ with_IN the_DT abundance_NN of_IN
          the_DT recombinant_JJ asbt_NN mRNA_NN encoded_JJ by_IN the_DT transgene_NN ._. The_DT
          uptake_NN of_IN 25_CD μM_NN TCA_NNP by_IN CHO_NNP ._. asbt_NN ._. 8_CD and_CC CHO_NNP ._. asbt_NN ._. 35_CD cells_NNS
          reached_VBD steady_JJ state_NN within_IN 10_CD min_NN (_( Figure_NN 3_CD D_NNP )_) ,_, implying_VBG
          the_DT presence_NN of_IN a_DT pathway_NN for_IN bile_NN acid_NN efflux_NN in_IN CHO_NNP
          cells_NNS ._. Furthermore_RB ,_, it_PRP was_VBD possible_JJ to_TO chase_VB the_DT
          incorporated_VBN radiolabeled_JJ TCA_NNP from_IN CHO_NNP ._. asbt_NN ._. 49_CD and_CC
          CHO_NNP ._. asbt_NN ._. 35_CD cells_NNS (_( Figure_NN 3_CD E_NNP )_) ._. These_DT results_NNS demonstrate_VBP
          that_IN CHO_NNP ._. asbt_NN cells_NNS express_VBP a_DT fully_RB functional_JJ asbt_NN
          protein_NN ._.
        
        
          Cytotoxic_NNP potential_NN of_IN bile_NN acids_NNS in_IN CHO_NNP ._. asbt_NN ._. 35_CD
          cells_NNS
          The_DT increase_NN of_IN LDH_NNP activity_NN in_IN the_DT culture_NN medium_NN of_IN
          CHO_NNP ._. asbt_NN ._. 35_CD and_CC McNtcp_NNP ._. 24_CD cells_NNS after_IN treatment_NN with_IN
          glycine-_NN and_CC taurine-conjugated_JJ bile_NN acids_NNS were_VBD compared_VBN
          to_TO assess_VB the_DT cytotoxic_JJ potential_NN of_IN bile_NN acids_NNS on_IN these_DT
          cells_NNS ._. The_DT CHO_NNP ._. asbt_NN ._. 35_CD cell_NN line_NN was_VBD chosen_VBN for_IN this_DT
          study_NN because_IN this_DT cell_NN line_NN has_VBZ bile_NN acid_NN uptake_NN
          activity_NN that_WDT was_VBD comparable_JJ to_TO McNtcp_NNP ._. 24_CD cells_NNS [_NN 17_CD ]_NN ._.
          LDH_NNP activity_NN in_IN the_DT culture_NN medium_NN of_IN McNtcp_NNP ._. 24_CD cells_NNS
          increased_VBN by_IN 20_CD to_TO 31_CD %_NN within_IN 2_CD h_NN of_IN incubating_VBG the_DT cells_NNS
          in_IN medium_NN containing_VBG 100_CD μM_NN of_IN glycine_NN conjugates_NNS of_IN
          cholic_JJ acid_NN ,_, chenodeoxycholic_JJ acid_NN ,_, and_CC deoxycholic_JJ acid_NN
          (_( GCA_NNP ,_, GCDCA_NNP ,_, GDCA_NNP ,_, respectively_RB )_) (_( Figure_NN 4_CD A_DT )_) ._. GCDCA_NNP was_VBD
          the_DT most_RBS potent_JJ in_IN inducing_VBG the_DT release_NN of_IN LDH_NNP among_IN the_DT
          bile_NN acids_NNS tested_VBN whereas_IN TCA_NNP had_VBD little_JJ effect_NN as_IN
          compared_VBN to_TO the_DT no_DT addition_NN controls_NNS ._. In_IN contrast_NN ,_,
          incubation_NN of_IN CHO_NNP ._. asbt_NN ._. 35_CD cells_NNS in_IN medium_NN containing_VBG 100_CD
          μM_NN of_IN taurine-_NN or_CC glycine-conjugated_JJ bile_NN acids_NNS resulted_VBD
          in_IN a_DT time_NN dependent_JJ increase_NN of_IN LDH_NNP activity_NN the_DT culture_NN
          medium_NN (_( Figure_NN 4_CD B_NNP )_) ._. GCA_NNP and_CC GCDCA_NNP were_VBD equally_RB potent_JJ in_IN
          increasing_VBG LDH_NNP activity_NN ,_, raising_VBG the_DT level_NN in_IN the_DT medium_NN
          of_IN treated_VBN cells_NNS by_IN 40_CD %_NN within_IN 6_CD h_NN ._. Taurine-conjugated_NNP
          bile_NN acids_NNS also_RB raised_VBD the_DT LDH_NNP activity_NN in_IN the_DT medium_NN of_IN
          treated_VBN cells_NNS to_TO levels_NNS approaching_VBG GDCA-treated_NNP cells_NNS
          (_( Figure_NN 4_CD B_NNP )_) ._. Treatment_NNP of_IN McArdle_NNP RH-_NNP 7777_CD and_CC CHO_NNP cells_NNS
          with_IN taurine-_NN or_CC glycine-conjugated_JJ bile_NN acids_NNS had_VBD little_JJ
          effect_NN on_IN the_DT release_NN of_IN LDH_NNP (_( Figure_NN 4_CD Cand_NNP 4_CD D_NNP )_) ,_,
          indicating_VBG that_DT bile_NN acid_NN uptake_NN activity_NN is_VBZ necessary_JJ to_TO
          manifest_JJ their_PRP$ cytotoxic_JJ potential_NN in_IN both_DT cell_NN lines_NNS ._. In_IN
          addition_NN ,_, the_DT cytotoxicity_NN was_VBD specific_JJ to_TO conjugated_JJ
          bile_NN acids_NNS since_IN the_DT addition_NN of_IN non-conjugated_JJ bile_NN
          acids_NNS to_TO the_DT culture_NN medium_NN of_IN bile_NN acid-transporting_JJ
          cells_NNS had_VBD a_DT negligible_JJ effect_NN on_IN the_DT release_NN of_IN LDH_NNP into_IN
          the_DT culture_NN medium_NN ._.
        
        
          Mechanism_NNP of_IN cell_NN death_NN
          Members_NNS of_IN the_DT caspase_NN family_NN of_IN cysteine_NN proteases_NNS
          have_VBP been_VBN implicated_VBN in_IN the_DT initiation_NN and_CC execution_NN
          phase_NN of_IN apoptosis_NNS [_NN 24_CD ]_NN ._. In_IN addition_NN ,_, several_JJ studies_NNS
          have_VBP shown_VBN the_DT activation_NN of_IN the_DT caspase_NN cascade_NN by_IN toxic_JJ
          bile_NN acids_NNS in_IN hepatocytes_NNS [_NN 25_CD 26_CD ]_NN ._. We_PRP thus_RB measured_VBD
          caspase_NN activity_NN after_IN bile_NN acid_NN treatment_NN in_IN CHO_NNP ._. asbt_NN ._. 35_CD
          cells_NNS ._. Activation_NNP of_IN caspase_NN 8_CD was_VBD detected_VBN in_IN
          CHO_NNP ._. asbt_NN ._. 35_CD cells_NNS after_IN treatment_NN with_IN either_DT taurine-_NN or_CC
          glycine-_NN conjugated_JJ bile_NN acids_NNS (_( Figure_NN 5_CD A_DT )_) ,_, but_CC absent_JJ in_IN
          bile_NN acid-treated_JJ CHO_NNP cells_NNS (_( Figures_NNS 5_CD A_DT )_) ._. Analysis_NNP of_IN
          genomic_JJ DNA_NNP isolated_VBD from_IN treated_VBN cells_NNS showed_VBD that_IN TCA_NNP
          and_CC GCDCA_NNP induced_VBD DNA_NNP laddering_VBG in_IN CHO_NNP ._. asbt_NN ._. 35_CD cells_NNS
          (_( Figure_NN 5_CD B_NNP )_) ,_, indicating_VBG that_IN both_DT classes_NNS of_IN conjugated_JJ
          bile_NN acids_NNS induce_VB apoptosis_NNS in_IN this_DT non-hepatic_JJ derived_VBN
          cell_NN line_NN ._. To_TO further_VB characterize_VB the_DT initiation_NN of_IN the_DT
          caspase_NN cascade_NN ,_, we_PRP determined_VBD the_DT time_NN course_NN of_IN caspase_NN
          activation_NN by_IN bile_NN acids_NNS in_IN CHO_NNP ._. asbt_NN ._. 35_CD and_CC McNtcp_NNP ._. 24_CD
          cells_NNS ._. Activation_NNP of_IN caspase_NN 8_CD in_IN both_DT cell_NN lines_NNS was_VBD
          first_RB detected_VBN by_IN 30_CD min_NN following_VBG GCDCA-treatment_NNP and_CC
          was_VBD maximal_NN by_IN 60_CD min_NN (_( Figure_NN 6_CD )_) ._. In_IN contrast_NN ,_,
          TCA-mediated_NNP activation_NN of_IN caspase_NN 8_CD was_VBD first_RB detected_VBD
          at_IN 60_CD min_NN and_CC reached_VBD the_DT levels_NNS induced_VBN by_IN GCDCA_NNP by_IN 120_CD
          min_NN ._.
          Because_IN the_DT bile_NN acid_NN transporters_NNS used_VBN to_TO establish_VB
          bile_NN acid_NN uptake_NN activity_NN in_IN McNtcp_NNP ._. 24_CD and_CC CHO_NNP ._. asbt_NN ._. 35_CD
          cells_NNS were_VBD not_RB the_DT same_JJ ,_, it_PRP was_VBD possible_JJ that_IN the_DT
          sensitivity_NN of_IN CHO_NNP ._. asbt_NN ._. 35_CD cells_NNS to_TO taurine-conjugated_JJ
          bile_NN acids_NNS was_VBD a_DT consequence_NN of_IN asbt_NN expression_NN ._. To_TO
          address_VB this_DT possibility_NN ,_, asbt_NN was_VBD expressed_VBN in_IN McArdle_NNP
          RH-_NNP 7777_CD cells_NNS and_CC then_RB tested_VBN for_IN response_NN to_TO glycine-_NN
          and_CC taurine-conjugated_JJ bile_NN acids_NNS ._. As_IN shown_VBN in_IN Figure_NN 7_CD A_DT ,_,
          asbt_NN conferred_VBD active_JJ bile_NN acid_NN uptake_NN activity_NN in_IN
          transfected_JJ cells_NNS ._. However_RB ,_, activation_NN of_IN caspase_NN 8_CD was_VBD
          evident_JJ only_RB in_IN the_DT cells_NNS that_WDT were_VBD treated_VBN with_IN GCDCA_NNP
          (_( Figure_NN 7_CD B_NNP )_) ._. These_DT results_NNS demonstrate_VBP that_IN the_DT
          sensitivity_NN of_IN this_DT cell_NN line_NN to_TO taurine-_NN and_CC
          glycine-conjugated_JJ bile_NN acids_NNS is_VBZ not_RB dependent_JJ on_IN a_DT
          specific_JJ kind_NN of_IN bile_NN acid_NN transporter_NN ._.
          Activation_NNP of_IN a_DT PI_NNP 3_CD K-_NNP dependent_JJ pathway_NN by_IN
          taurine-conjugated_JJ bile_NN acids_NNS appears_VBZ to_TO decide_VB the_DT fate_NN
          of_IN McNtcp_NNP ._. 24_CD cells_NNS (_( Figure_NN 2_CD and_CC ref_NN ._. [_NN 21_CD ]_NN )_) ._. Therefore_RB ,_,
          we_PRP determined_VBD if_IN PI_NNP 3_CD K_NNP activity_NN was_VBD altered_VBN in_IN bile_NN
          acid-treated_JJ CHO_NNP ._. asbt_NN ._. 35_CD cells_NNS ._. As_IN shown_VBN in_IN Figure_NN 8_CD ,_,
          PI_NNP 3_CD K_NNP activity_NN in_IN response_NN to_TO TCA_NNP or_CC GCDCA_NNP was_VBD not_RB evident_JJ
          in_IN CHO_NNP ._. asbt_NN ._. 35_CD cells_NNS ,_, suggesting_VBG that_IN the_DT inability_NN to_TO
          activate_VBP survival_NN pathways_NNS by_IN taurine-conjugated_JJ bile_NN
          acids_NNS commit_VBP these_DT cells_NNS to_TO apoptosis_NNS ._. These_DT findings_NNS
          also_RB indicate_VBP that_DT liver_NN derived_VBD cells_NNS posses_NNS a_DT mechanism_NN
          that_WDT responds_VBZ to_TO taurine-conjugated_JJ bile_NN acids_NNS leading_VBG to_TO
          the_DT activation_NN of_IN PI_NNP 3_CD K_NNP ._.
        
        
          Cytotoxic_NNP potential_NN of_IN bile_NN acids_NNS in_IN
          HBAB-expressing_NNP McNtcp_NNP ._. 24_CD cells_NNS
          It_PRP has_VBZ been_VBN suggested_VBN that_DT sequestration_NN of_IN bile_NN acids_NNS
          by_IN intracellular_NN bile_NN acid_NN binding_JJ proteins_NNS may_MD also_RB
          protect_VB cells_NNS from_IN bile_NN acid_NN cytotoxicity_NN ._. Thus_RB ,_, the_DT
          human_JJ bile_NN acid_NN binder_NN (_( HBAB_NNP )_) was_VBD expressed_VBN in_IN McNtcp_NNP ._. 24_CD
          cells_NNS to_TO determine_VB if_IN this_DT class_NN of_IN proteins_NNS can_MD protect_VB
          against_IN GCDCA_NNP cytotoxicity_NN ._. Figure_NN 9_CD Ashows_NNP the_DT presence_NN
          of_IN the_DT recombinant_JJ mRNA_NN encoding_VBG the_DT recombinant_JJ HBAB_NNP in_IN
          clones_NNS that_WDT have_VBP incorporated_VBN the_DT HBAB_NNP expression_NN vector_NN
          into_IN their_PRP$ genomes_NNS ._. In_IN addition_NN ,_, the_DT HBAB_NNP protein_NN
          abundance_NN in_IN the_DT total_JJ lysates_NNS correlated_JJ with_IN the_DT
          abundance_NN of_IN the_DT HBAB_NNP mRNA_NN (_( Figure_NN 9_CD A_DT )_) ._. Analysis_NNP of_IN
          radiolabeled_JJ TCA_NNP uptake_NN (_( Figure_NN 9_CD B_NNP )_) showed_VBD that_DT
          expression_NN of_IN HBAB_NNP had_VBD minimal_JJ impact_NN on_IN bile_NN acid_NN uptake_NN
          despite_IN the_DT fact_NN that_IN the_DT range_NN of_IN HBAB_NNP protein_NN abundance_NN
          was_VBD up_IN to_TO 5_CD -_: fold_VB greater_JJR than_IN that_DT in_IN the_DT lowest_JJS HBAB_NNP
          expressing_VBG cell_NN ._. Moreover_RB ,_, the_DT rates_NNS of_IN decline_NN in_IN the_DT
          amount_NN of_IN radiolabeled_JJ TCA_NNP associated_VBN with_IN the_DT cells_NNS
          after_IN withdrawal_NN of_IN the_DT radiolabeled_JJ bile_NN acids_NNS from_IN the_DT
          culture_NN medium_NN was_VBD comparable_JJ among_IN the_DT different_JJ clones_NNS
          (_( Figure_NN 9_CD C_NNP )_) ,_, indicating_VBG that_IN the_DT rate_NN of_IN bile_NN acid_NN efflux_NN
          from_IN these_DT cells_NNS was_VBD also_RB not_RB affected_VBN by_IN the_DT presence_NN of_IN
          HBAB_NNP ._.
          Incubation_NNP of_IN the_DT BN_NNP clones_NNS with_IN GCDCA_NNP increased_VBD the_DT
          LDH_NNP activity_NN in_IN the_DT culture_NN medium_NN to_TO a_DT level_NN similar_JJ to_TO
          that_DT in_IN the_DT medium_NN of_IN GCDCA-treated_NNP McNtcp_NNP ._. 24_CD cells_NNS
          (_( Figure_NN 10_CD A_DT )_) ._. In_IN addition_NN ,_, caspase_NN 8_CD activity_NN in_IN bile_NN
          acid-treated_JJ BN_NNP ._. 25_CD ,_, BN_NNP ._. 46_CD and_CC BN_NNP ._. 49_CD was_VBD comparable_JJ to_TO
          that_DT in_IN McNtcp_NNP ._. 24_CD ,_, which_WDT were_VBD elevated_VBD compared_VBN to_TO that_DT
          in_IN McArdle_NNP RH-_NNP 7777_CD cells_NNS (_( Figure_NN 10_CD B_NNP )_) ._. The_DT time_NN course_NN of_IN
          caspase_NN 8_CD activation_NN in_IN BN_NNP cells_NNS after_IN treatment_NN with_IN 10_CD
          μM_NN bile_NN acids_NNS was_VBD similar_JJ to_TO that_DT observed_VBD for_IN McNtcp_NNP ._. 24_CD
          cells_NNS (_( Figure_NN 10_CD C_NNP )_) ._. Therefore_RB ,_, the_DT presence_NN of_IN an_DT
          intracellular_NN bile_NN acid_NN binding_JJ protein_NN did_VBD not_RB protect_VB
          these_DT cells_NNS from_IN glycine-conjugated_JJ bile_NN acid_NN
          cytotoxicity_NN ,_, even_RB at_IN low_JJ bile_NN acid_NN concentrations_NNS ._. These_DT
          results_NNS indicate_VBP that_IN the_DT activation_NN of_IN a_DT signaling_VBG
          cascade_NN involving_VBG PI_NNP 3_CD K_NNP is_VBZ the_DT dominant_JJ mechanism_NN
          responsible_JJ for_IN protecting_VBG McNtcp_NNP ._. 24_CD cells_NNS from_IN the_DT
          cytotoxicity_NN of_IN glycine-conjugated_JJ bile_NN acids_NNS ._.
        
      
      
        Discussion_NNP
        In_IN this_DT study_NN ,_, we_PRP determined_VBD if_IN the_DT differential_NN
        sensitivity_NN elaborated_JJ by_IN the_DT liver-derived_JJ McNtcp_NNP ._. 24_CD cell_NN
        line_NN to_TO different_JJ classes_NNS of_IN conjugated_JJ bile_NN acids_NNS is_VBZ
        limited_VBN to_TO cells_NNS that_WDT normally_RB transport_NN bile_NN acids_NNS ._. We_PRP
        previously_RB demonstrated_VBD that_IN taurine-conjugated_JJ bile_NN acids_NNS
        are_VBP not_RB toxic_JJ to_TO McNtcp_NNP ._. 24_CD cells_NNS [_NN 18_CD ]_NN ._. In_IN contrast_NN ,_,
        glycine-conjugated_JJ bile_NN acids_NNS induce_VB apoptosis_NNS in_IN McNtcp_NNP ._. 24_CD
        cells_NNS and_CC primary_JJ mouse_NN hepatocytes_NNS ,_, through_IN activation_NN of_IN
        the_DT Fas_NNP receptor_NN in_IN a_DT FasL-independent_NNP manner_NN [_NN 19_CD 25_CD ]_NN ._.
        Moreover_RB ,_, GCDCA_NNP was_VBD demonstrated_VBN to_TO activate_VBP both_DT initiator_NN
        and_CC effector_NN caspases_NNS ,_, and_CC that_IN the_DT apoptotic_JJ response_NN can_MD
        be_VB blocked_VBN by_IN Crm_NNP A_DT ,_, a_DT caspase_NN 8_CD inhibitor_NN [_NN 25_CD ]_NN ._. The_DT
        mechanism_NN by_IN which_WDT bile_NN acids_NNS stimulate_VB the_DT activation_NN of_IN
        Fas_NNP receptor_NN remains_VBZ unclear_JJ ._. In_IN Fas_NNP deficient_NN hepatocytes_NNS ,_,
        toxic_JJ bile_NN acids_NNS were_VBD still_RB able_JJ to_TO induce_VB apoptosis_NNS ,_,
        suggesting_VBG that_IN bile_NN acids_NNS are_VBP capable_JJ of_IN stimulating_VBG
        multiple_JJ pathways_NNS to_TO initiate_VB cell_NN death_NN [_NN 26_CD ]_NN ._.
        To_TO gain_VB further_JJ insight_NN into_IN the_DT specificity_NN of_IN bile_NN
        acid_NN cytotoxicity_NN ,_, we_PRP conferred_VBD active_JJ bile_NN acid_NN uptake_NN
        capacity_NN in_IN CHO_NNP cells_NNS ,_, a_DT cell_NN type_NN that_WDT does_VBZ not_RB normally_RB
        metabolize_NN bile_NN acids_NNS ,_, by_IN expressing_VBG a_DT bile_NN acid_NN
        transporter_NN ._. CHO_NNP ._. asbt_NN cells_NNS produce_VBP recombinant_JJ asbt_NN with_IN a_DT
        molecular_JJ mass_NN and_CC kinetic_JJ parameters_NNS that_WDT are_VBP similar_JJ to_TO
        previously_RB reported_VBD values_NNS [_NN 6_CD ]_NN ._. It_PRP is_VBZ not_RB known_VBN if_IN CHO_NNP
        cells_NNS have_VBP pathways_NNS capable_JJ of_IN facilitating_VBG the_DT efflux_NN of_IN
        bile_NN acids_NNS out_IN of_IN the_DT cell_NN ._. The_DT apparent_JJ efflux_NN observed_VBD in_IN
        CHO_NNP ._. asbt_NN ._. 35_CD could_MD be_VB attributed_VBN to_TO the_DT fact_NN that_DT asbt_NN is_VBZ
        capable_JJ a_DT bidirectional_NN transport_NN of_IN bile_NN acids_NNS [_NN 27_CD ]_NN ._.
        However_RB ,_, it_PRP is_VBZ conceivable_JJ that_IN an_DT efflux_NN mechanism_NN that_WDT
        recognizes_VBZ bile_NN acids_NNS exists_VBZ in_IN CHO_NNP cells_NNS and_CC other_JJ
        mammalian_JJ cells_NNS ._. Indeed_RB ,_, yeast_NN and_CC plants_NNS express_VBP proteins_NNS
        capable_JJ of_IN active_JJ bile_NN acid_NN transport_NN [_NN 28_CD ]_NN ._. As_IN these_DT
        organisms_NNS do_VBP not_RB normally_RB synthesize_VB bile_NN acids_NNS ,_, their_PRP$
        ability_NN to_TO transport_VB bile_NN acids_NNS may_MD illustrate_VB a_DT
        generalized_JJ mechanism_NN for_IN cellular_JJ transport_NN of_IN hydrophobic_JJ
        organic_JJ anions_NNS ._.
        CHO_NNP ._. asbt_NN ._. 35_CD cells_NNS were_VBD used_VBN as_IN a_DT model_NN to_TO assess_VB the_DT
        cytotoxic_JJ potential_NN of_IN taurine-_NN and_CC glycine-conjugated_JJ bile_NN
        acids_NNS in_IN non-hepatic_JJ derived_VBN and_CC non-bile_JJ acid_NN metabolizing_VBG
        cells_NNS ._. Unlike_IN McNtcp_NNP ._. 24_CD cells_NNS ,_, treatment_NN of_IN CHO_NNP ._. asbt_NN clones_NNS
        with_IN taurine-conjugated_JJ bile_NN acids_NNS resulted_VBD in_IN cell_NN death_NN ._.
        TCA_NNP was_VBD the_DT most_RBS potent_JJ of_IN taurine-conjugated_JJ bile_NN acid_NN
        tested_VBN ._. It_PRP is_VBZ unlikely_JJ that_IN the_DT observed_VBN cytotoxicity_NN of_IN
        the_DT conjugated_JJ bile_NN acids_NNS could_MD be_VB attributed_VBN to_TO the_DT
        generalized_JJ intracellular_NN accumulation_NN of_IN bile_NN acids_NNS
        because_IN unconjugated_JJ bile_NN acids_NNS were_VBD transported_VBN by_IN
        CHO_NNP ._. asbt_NN cells_NNS but_CC did_VBD not_RB cause_VB significant_JJ release_NN of_IN LDH_NNP
        into_IN the_DT culture_NN medium_NN (_( Torchia_NNP and_CC Agellon_NNP ,_, unpublished_JJ
        observations_NNS )_) ._. In_IN contrast_NN ,_, glycine-conjugated_JJ bile_NN acids_NNS
        (_( GCDCA_NNP in_IN particular_JJ )_) were_VBD highly_RB effective_JJ at_IN causing_VBG the_DT
        increase_NN in_IN LDH_NNP activity_NN in_IN the_DT culture_NN medium_NN of_IN both_DT
        McNtcp_NNP ._. 24_CD and_CC CHO_NNP ._. asbt_NN ._. 35_CD cells_NNS ._. Primary_JJ hepatocytes_NNS
        exhibit_NN differential_NN sensitivity_NN to_TO taurine-_NN and_CC
        glycine-conjugated_JJ bile_NN acids_NNS in_IN culture_NN [_NN 29_CD ]_NN ._. The_DT bile_NN
        acid-transporting_JJ WIF-B_NNP cells_NNS ,_, which_WDT are_VBP rat_NN hepatoma-human_JJ
        fibroblast_NN hybrids_NNS [_NN 30_CD ]_NN ,_, remain_VB viable_JJ even_RB when_WRB grown_VBN
        in_IN TCA-containing_NNP culture_NN medium_NN for_IN up_IN to_TO 14_CD days_NNS [_NN 31_CD ]_NN ._.
        In_IN contrast_NN ,_, our_PRP$ study_NN shows_VBZ that_IN taurine-conjugated_JJ bile_NN
        acids_NNS is_VBZ toxic_JJ to_TO a_DT cell_NN type_NN that_WDT is_VBZ not_RB normally_RB exposed_VBN
        to_TO bile_NN acids_NNS ._. Liver_NNP cells_NNS ,_, which_WDT normally_RB metabolize_NN bile_NN
        acids_NNS ,_, apparently_RB possess_VBP a_DT mechanism_NN that_WDT can_MD distinguish_VB
        and_CC differentially_RB elaborate_VB distinct_JJ biological_JJ activities_NNS
        of_IN taurine-_NN and_CC glycine-conjugated_JJ bile_NN acids_NNS ._.
        Both_DT taurine-_NN and_CC glycine-conjugated_JJ bile_NN acids_NNS induce_VB
        apoptotic_JJ cell_NN death_NN in_IN CHO_NNP ._. asbt_NN ._. 35_CD cells_NNS ._. The_DT involvement_NN
        of_IN the_DT caspase_NN cascade_NN in_IN CHO_NNP ._. asbt_NN ._. 35_CD cells_NNS was_VBD illustrated_VBN
        by_IN the_DT fact_NN that_IN conjugated_JJ bile_NN acids_NNS activated_VBN caspase_NN 8_CD
        in_IN a_DT time_NN dependent_JJ manner_NN ._. However_RB ,_, the_DT different_JJ profile_NN
        of_IN caspase_NN 8_CD activation_NN suggests_VBZ that_DT taurine-_NN and_CC
        glycine-conjugated_JJ bile_NN acids_NNS may_MD trigger_VB apoptosis_NNS by_IN
        different_JJ pathways_NNS ._. At_IN present_JJ ,_, it_PRP is_VBZ not_RB known_VBN how_WRB
        conjugated_JJ bile_NN acids_NNS activate_VBP caspases_NNS in_IN CHO_NNP ._. asbt_NN ._. 35_CD
        cells_NNS ._. A_DT protein_NN that_WDT is_VBZ immunoreactive_JJ to_TO a_DT Fas_NNP receptor_NN
        antiserum_NN and_CC has_VBZ a_DT molecular_JJ mass_NN similar_JJ to_TO the_DT rat_NN Fas_NNP
        receptor_NN is_VBZ detectable_JJ in_IN CHO_NNP cell_NN extracts_NNS (_( Torchia_NNP and_CC
        Agellon_NNP ,_, unpublished_JJ results_NNS )_) ._. This_DT leaves_VBZ the_DT possibility_NN
        that_IN conjugated_JJ bile_NN acids_NNS may_MD activate_VBP the_DT apoptotic_JJ
        cascade_NN through_IN Fas_NNP receptor_NN in_IN this_DT cell_NN line_NN ,_, as_IN
        glycine-conjugated_JJ bile_NN acids_NNS do_VBP in_IN hepatocytes_NNS [_NN 25_CD ]_NN ._.
        However_RB ,_, the_DT activation_NN of_IN caspases_NNS does_VBZ not_RB require_VB a_DT
        specific_JJ kind_NN of_IN bile_NN acid_NN transporter_NN since_IN TCA_NNP is_VBZ not_RB
        toxic_JJ to_TO McArdle_NNP RH-_NNP 7777_CD cells_NNS irrespective_RB of_IN whether_IN
        these_DT cells_NNS internalize_NN bile_NN acids_NNS via_IN ntcp_NN or_CC asbt_NN ._.
        The_DT differential_NN response_NN of_IN McNtcp_NNP ._. 24_CD cells_NNS to_TO
        different_JJ classes_NNS of_IN conjugated_JJ bile_NN acids_NNS is_VBZ apparently_RB
        due_JJ to_TO the_DT selective_JJ activation_NN of_IN either_DT a_DT PI_NNP 3_CD K-_NNP dependent_JJ
        survival_NN pathway_NN [_NN 22_CD 23_CD ]_NN or_CC caspase-dependent_JJ death_NN
        pathway_NN [_NN 32_CD ]_NN ._. Indeed_RB ,_, neither_DT taurine-_NN nor_CC
        glycine-conjugated_JJ bile_NN acids_NNS stimulated_VBN PI_NNP 3_CD K_NNP activity_NN in_IN
        CHO_NNP ._. asbt_NN ._. 35_CD cells_NNS and_CC both_DT classes_NNS of_IN bile_NN acids_NNS were_VBD
        toxic_JJ ._. In_IN addition_NN ,_, pre-treatment_JJ of_IN McNtcp_NNP ._. 24_CD cells_NNS with_IN a_DT
        PI_NNP 3_CD K_NNP inhibitor_NN rendered_VBD these_DT cells_NNS susceptible_JJ to_TO TCA-_NNP and_CC
        TCDCA-_NNP mediated_JJ cell_NN death_NN ._. The_DT latter_JJ finding_NN indicates_VBZ
        that_IN taurine-conjugated_JJ bile_NN acids_NNS are_VBP capable_JJ of_IN inducing_VBG
        apoptosis_NNS when_WRB PI_NNP 3_CD K_NNP is_VBZ inhibited_VBD ,_, probably_RB by_IN utilizing_VBG the_DT
        same_JJ mechanism_NN activated_VBN by_IN glycine-conjugated_JJ bile_NN acids_NNS ._.
        That_DT TCA_NNP is_VBZ able_JJ to_TO activate_VBP PI_NNP 3_CD K_NNP in_IN plasma_NN membrane_NN
        fractions_NNS from_IN McNtpc_NNP ._. 24_CD agrees_VBZ with_IN a_DT previous_JJ study_NN
        showing_VBG that_IN TCA_NNP increases_NNS PI_NNP 3_CD K_NNP activity_NN in_IN canalicular_NN and_CC
        sinusoidal_NN membrane_NN vesicles_NNS [_NN 16_CD ]_NN ._. The_DT activation_NN of_IN
        PI_NNP 3_CD K_NNP in_IN that_DT report_NN was_VBD also_RB associated_VBN with_IN recruitment_NN of_IN
        sister_NN of_IN P-_NNP glycoprotein_NN (_( the_DT bile_NN acid_NN export_NN pump_NN )_) and_CC
        other_JJ multidrug_NN resistance_NN proteins_NNS to_TO the_DT canalicular_NN
        membrane_NN [_NN 16_CD ]_NN ._. Extended_NNP treatment_NN of_IN McNtcp_NNP ._. 24_CD cells_NNS
        does_VBZ not_RB appear_VB to_TO have_VB detrimental_JJ and_CC permanent_JJ
        consequences_NNS on_IN cellular_JJ function_NN ._. The_DT marked_VBD morphological_JJ
        changes_NNS that_WDT occur_VBP during_IN long_JJ term_NN incubation_NN with_IN TCA_NNP [_NN
        18_CD ]_NN dissipate_VB after_IN the_DT withdrawal_NN of_IN the_DT bile_NN acid_NN from_IN
        the_DT culture_NN medium_NN ,_, and_CC the_DT cells_NNS remain_VBP viable_JJ ._.
        The_DT significance_NN of_IN an_DT intracellular_NN and_CC high_JJ affinity_NN
        bile_NN acid_NN binder_NN in_IN bile_NN acid_NN mediated_JJ cytotoxicity_NN was_VBD
        also_RB evaluated_VBN ._. Several_JJ proteins_NNS capable_JJ of_IN binding_JJ bile_NN
        acids_NNS in_IN vitro_NN have_VBP been_VBN identified_VBN (_( reviewed_VBN in_IN ref_NN ._. [_NN 1_CD ]_NN
        )_) ._. It_PRP is_VBZ thought_VBN that_IN the_DT major_JJ bile_NN acid_NN binding_JJ protein_NN
        in_IN the_DT cytosol_NN of_IN rat_NN hepatocytes_NNS is_VBZ 3_CD α-hydroxysteroid_JJ
        dehydrogenase_NN ,_, a_DT member_NN of_IN the_DT aldo_NN keto_NN reductase_NN
        supergene_NN family_NN [_NN 33_CD ]_NN ._. However_RB ,_, the_DT exact_JJ role_NN of_IN this_DT
        protein_NN in_IN intracellular_NN transport_NN of_IN bile_NN acids_NNS and_CC
        cytoprotection_NN was_VBD undefined_JJ ._. HBAB_NNP ,_, a_DT member_NN of_IN the_DT human_JJ
        aldo_NN keto_NN reductase_NN gene_NN family_NN ,_, has_VBZ been_VBN shown_VBN to_TO bind_NN
        bile_NN acids_NNS with_IN high_JJ affinity_NN (_( <_NN 1_CD μM_NN )_) and_CC is_VBZ postulated_JJ
        to_TO play_VB a_DT similar_JJ role_NN as_IN 3_CD α-hydroxysteroid_JJ dehydrogenase_NN
        in_IN human_JJ hepatocytes_NNS [_NN 33_CD ]_NN ._. Expression_NNP of_IN HBAB_NNP in_IN
        McNtcp_NNP ._. 24_CD cells_NNS was_VBD expected_VBN to_TO increase_VB the_DT capacity_NN of_IN
        these_DT cells_NNS to_TO sequester_VB bile_NN acids_NNS in_IN the_DT cytoplasm_NN ,_, and_CC
        thereby_RB reduce_VB their_PRP$ toxicity_NN ._. High_JJ level_NN expression_NN of_IN
        HBAB_NNP had_VBD a_DT negligible_JJ effect_NN on_IN the_DT ability_NN of_IN the_DT BN_NNP
        clones_NNS to_TO take_VB up_RP or_CC secrete_NN bile_NN acids_NNS ,_, suggesting_VBG that_IN
        HBAB_NNP has_VBZ a_DT minor_JJ role_NN in_IN the_DT net_JJ transport_NN of_IN bile_NN acids_NNS in_IN
        these_DT cells_NNS ._. More_RBR importantly_RB however_RB ,_, expression_NN of_IN HBAB_NNP
        in_IN McNtcp_NNP ._. 24_CD cells_NNS had_VBD no_DT effect_NN on_IN GCDCA-induced_NNP cell_NN
        death_NN ,_, even_RB at_IN low_JJ bile_NN acid_NN concentrations_NNS ,_, indicating_VBG
        that_IN this_DT class_NN of_IN protein_NN does_VBZ not_RB provide_VB cytoprotection_NN
        against_IN toxic_JJ bile_NN acids_NNS as_RB previously_RB suspected_VBN ._. This_DT
        finding_VBG is_VBZ consistent_JJ with_IN the_DT idea_NN that_IN bile_NN acids_NNS
        directly_RB modulate_VBP specific_JJ signaling_VBG cascades_NNS that_WDT control_NN
        cellular_JJ death_NN and_CC survival_NN ._.
        In_IN summary_NN ,_, the_DT failure_NN of_IN CHO_NNP ._. asbt_NN cells_NNS to_TO tolerate_VB
        taurine-conjugated_JJ bile_NN acids_NNS has_VBZ revealed_VBN the_DT existence_NN of_IN
        a_DT mechanism_NN that_WDT may_MD be_VB specific_JJ for_IN cells_NNS that_WDT normally_RB
        metabolize_NN bile_NN acids_NNS ._. Since_IN bile_NN acids_NNS undergo_VBP
        enterohepatic_JJ circulation_NN ,_, it_PRP would_MD be_VB reasonable_JJ to_TO expect_VB
        the_DT existence_NN of_IN the_DT same_JJ mechanism_NN in_IN other_JJ cell_NN types_NNS
        that_WDT naturally_RB transport_NN bile_NN acids_NNS ,_, such_JJ as_IN ileocytes_NNS and_CC
        cholangiocytes_NNS [_NN 34_CD 35_CD ]_NN ._. The_DT last_JJ few_JJ years_NNS have_VBP brought_VBN
        significant_JJ advances_NNS in_IN our_PRP$ understanding_NN of_IN bile_NN acid_NN
        transport_NN in_IN liver_NN and_CC intestinal_NN cells_NNS ._. However_RB ,_, the_DT
        regulatory_JJ potential_NN of_IN bile_NN acids_NNS is_VBZ only_RB beginning_VBG to_TO be_VB
        realized_VBN ._. With_IN the_DT recent_JJ discovery_NN that_IN bile_NN acids_NNS
        represent_VBP the_DT natural_JJ ligands_NNS for_IN the_DT nuclear_JJ receptor_NN FXR_NNP
        [_NN 10_CD 11_CD 12_CD ]_NN ,_, there_EX is_VBZ heightened_VBN interest_NN in_IN identifying_VBG
        the_DT genes_NNS that_WDT are_VBP regulated_VBN by_IN bile_NN acids_NNS ._. Insight_NNP into_IN
        how_WRB bile_NN acids_NNS directly_RB modulate_VBP a_DT variety_NN of_IN other_JJ
        cellular_JJ functions_NNS will_MD be_VB important_JJ in_IN understanding_VBG the_DT
        significance_NN of_IN cellular_JJ responses_NNS to_TO bile_NN acids_NNS ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Materials_NNS
          Tissue_NNP culture_NN reagents_NNS were_VBD purchased_VBN from_IN Canadian_NNP
          Life_NNP Technologies_NNPS (_( Burlington_NNP ,_, ON_NNP ,_, Canada_NNP )_) ._. [_NN
          3_CD H_NNP ]_NN -_: Taurocholic_NNP acid_NN (_( 2_CD ._. 6_CD Ci_NNP /_NN mmol_NN )_) ,_, [_NN 32_CD P_NN ]_NN -_: dCTP_NN (_( 3000_CD
          Ci_NNP /_NN mmol_NN )_) ,_, and_CC [_NN 32_CD P_NN ]_NN -_: ATP_NNP (_( 3000_CD Ci_NNP /_NN mmol_NN )_) were_VBD purchased_VBN
          from_IN Amersham_NNP Pharmacia_NNP Biotech_NNP (_( Baie_NNP d_SYM '_POS Urfe_NNP ,_, QC_NNP ,_,
          Canada_NNP )_) ._. Bile_NNP acids_NNS were_VBD obtained_VBN from_IN Sigma-_NNP Aldrich_NNP
          Canada_NNP Ltd_NNP ._. (_( Oakville_NNP ,_, ON_NNP ,_, Canada_NNP )_) and_CC
          Calbiochem-_NNP NovaBiochem_NNP Corp_NNP ._. (_( San_NNP Diego_NNP ,_, CA_NNP ,_, USA_NNP )_) ._. Other_JJ
          reagents_NNS purchased_VBN from_IN various_JJ commercial_JJ suppliers_NNS were_VBD
          of_IN analytical_JJ grade_NN ._.
        
        
          Cell_NNP lines_NNS
          McNtcp_NNP ._. 24_CD cells_NNS were_VBD cultured_JJ as_IN described_VBN previously_RB
          [_NN 17_CD ]_NN ._. Chinese_JJ hamster_NN ovary_JJ K_NNP 1_CD cells_NNS were_VBD cultured_JJ in_IN
          Ham_NNP 's_POS F_NN 12_CD medium_NN supplemented_JJ with_IN 10_CD %_NN fetal_JJ bovine_JJ
          serum_NN ._. To_TO establish_VB cell_NN lines_NNS stably_RB expressing_VBG asbt_NN ,_, a_DT
          cDNA_NN encoding_VBG the_DT hamster_NN asbt_NN [_NN 36_CD ]_NN was_VBD cloned_VBN into_IN
          pBK-CMV_JJ expression_NN vector_NN (_( Stratagene_NNP ,_, La_NNP Jolla_NNP ,_, CA_NNP )_) ._. The_DT
          prokaryotic_JJ promoter_NN embedded_VBN in_IN the_DT 5_CD '_POS -_: untranslated_JJ
          region_NN of_IN the_DT encoded_JJ recombinant_JJ eukaryotic_JJ mRNA_NN was_VBD
          removed_VBN from_IN the_DT resulting_VBG plasmid_NN ._. The_DT human_JJ bile_NN acid_NN
          binder_NN (_( HBAB_NNP )_) cDNA_NN [_NN 37_CD ]_NN was_VBD cloned_VBN into_IN a_DT derivative_NN of_IN
          pCep_NN 4_CD (_( Invitrogen_NNP Corp_NNP ._. ,_, Carlsbad_NNP ,_, CA_NNP )_) ,_, that_WDT had_VBD been_VBN
          previously_RB modified_VBN by_IN deleting_VBG the_DT EBNA_NNP 1_CD gene_NN [_NN 38_CD ]_NN ._.
          The_DT lipofectamine_NN reagent_NN (_( Canadian_NNP Life_NNP Technologies_NNPS )_)
          was_VBD used_VBN to_TO transfect_NN the_DT expression_NN plasmid_NN into_IN CHO_NNP ,_,
          McArdle_NNP RH_NNP 7777_CD ,_, and_CC McNtcp_NNP ._. 24_CD cells_NNS ._. The_DT cell_NN medium_NN was_VBD
          replaced_VBN 24_CD h_NN post-transfection_JJ with_IN medium_NN containing_VBG
          G_NNP 418_CD (_( 400_CD μg_NN /_NN ml_NN )_) or_CC hygromycin_NN (_( 500_CD μg_NN /_NN ml_NN )_) to_TO select_VB for_IN
          stable_JJ transfectants_NNS ._. Surviving_VBG colonies_NNS were_VBD expanded_VBN
          and_CC assayed_JJ for_IN the_DT ability_NN to_TO take_VB up_RP [_NN 3_CD H_NNP ]_NN -_: TCA_NNP from_IN the_DT
          culture_NN medium_NN as_IN described_VBN previously_RB [_NN 17_CD ]_NN or_CC assayed_JJ
          for_IN the_DT expression_NN of_IN HBAB_NNP by_IN immunoblotting_VBG ._.
        
        
          RNA_NNP and_CC immunoblot_NN analyses_NNS
          Total_NNP RNA_NNP from_IN CHO_NNP ._. asbt_NN and_CC BN_NNP cells_NNS was_VBD prepared_VBN and_CC
          analyzed_VBN by_IN RNA_NNP blotting_VBG as_RB previously_RB described_VBD [_NN 17_CD ]_NN ._.
          Cell_NNP lysates_NNS were_VBD prepared_VBN by_IN lysing_VBG cells_NNS in_IN 50_CD mM_NN
          Tris-_NNP HCl_NNP (_( pH_NN 7_CD ._. 4_LS )_) ,_, 1_CD %_NN NP-_NNP 40_CD %_NN ,_, 0_CD ._. 25_CD %_NN sodium_NN deoxycholate_NN ;_:
          150_CD mM_NN NaCl_NNP ,_, 1_CD mM_NN EGTA_NNP ,_, 1_CD mM_NN Na_NNP 
          3_CD VO_NNP 
          4_CD ,_, 1_CD mM_NN sodium_NN fluoride_NN ,_, containing_VBG a_DT
          protease_NN inhibitor_NN cocktail_NN (_( Sigma-_NNP Aldrich_NNP Canada_NNP Ltd_NNP ._. )_) ._.
          The_DT lysates_NNS were_VBD fractionated_JJ by_IN polyacrylamide_NN gel_NN
          electrophoresis_NNS and_CC then_RB transferred_VBN to_TO Immobilon-_NNP P_NN
          membrane_NN (_( Millipore_NNP Ltd_NNP ._. ,_, Nepean_NNP ,_, ON_NNP )_) ._. Asbt_NNP was_VBD detected_VBN
          using_VBG a_DT rabbit_NN antiserum_NN directed_VBN against_IN the_DT last_JJ 14_CD
          amino_JJ acids_NNS of_IN the_DT carboxyl_NN terminal_NN of_IN the_DT hamster_NN asbt_NN
          protein_NN ._. HBAB_NNP protein_NN was_VBD detected_VBN as_RB previously_RB
          described_VBD [_NN 37_CD ]_NN ._.
        
        
          Bile_NNP acid_NN uptake_NN activity_NN assay_NN
          Uptake_NNP studies_NNS in_IN CHO_NNP ._. asbt_NN ,_, BN_NNP and_CC McNtcp_NNP ._. 24_CD cells_NNS
          were_VBD done_VBN as_RB previously_RB described_VBD [_NN 17_CD ]_NN ._. Protein_NNP
          content_NN was_VBD determined_VBN using_VBG the_DT Bradford_NNP method_NN [_NN 39_CD ]_NN
          with_IN bovine_JJ serum_NN albumin_NN as_IN the_DT standard_NN ._.
        
        
          Lactate_NNP dehydrogenase_NN (_( LDH_NNP )_) assay_NN
          Cells_NNP (_( 10_CD 4_CD per_IN well_RB )_) were_VBD grown_VBN on_IN 24_CD well_RB multiwell_NN
          plates_NNS for_IN 16_CD h_NN ._. The_DT cells_NNS were_VBD then_RB washed_VBN with_IN
          phosphate_NN buffered_JJ saline_NN (_( PBS_NNP )_) and_CC then_RB incubated_JJ in_IN
          medium_NN (_( Ham_NNP 's_POS F_NN 12_CD or_CC Dulbecco_NNP 's_POS modified_VBN Eagle_NNP 's_POS medium_NN
          (_( DMEM_NNP )_) )_) containing_VBG 100_CD μM_NN bile_NN acids_NNS for_IN 1_CD to_TO 5_CD h_NN as_IN
          detailed_JJ in_IN the_DT Figure_NN legends_NNS ._. The_DT media_NNS was_VBD collected_VBN
          and_CC adjusted_VBN to_TO 0_CD ._. 1_CD %_NN Triton_NNP X-_NNP 100_CD ._. Cells_NNP remaining_VBG on_IN the_DT
          dish_NN were_VBD dissolved_VBN in_IN medium_NN (_( Ham_NNP 's_POS F_NN 12_CD or_CC DMEM_NNP )_)
          containing_VBG 0_CD ._. 1_CD %_NN Triton_NNP X-_NNP 100_CD ._. LDH_NNP activities_NNS in_IN both_DT the_DT
          cell_NN lysates_NNS and_CC media_NNS were_VBD measured_VBN as_IN described_VBN
          previously_RB [_NN 40_CD ]_NN ._.
        
        
          Visualization_NNP of_IN genomic_JJ DNA_NNP fragmentation_NN
          Cells_NNP (_( 10_CD 6_CD per_IN 60_CD mm_NN dish_NN )_) were_VBD grown_VBN for_IN 16_CD h_NN ._. After_IN
          washing_VBG with_IN PBS_NNP ,_, the_DT cells_NNS were_VBD incubated_JJ with_IN 50_CD μM_NN
          bile_NN acids_NNS for_IN 3_CD h_NN at_IN 37_CD °_NN C_NNP ._. Adherent_NNP and_CC non-adherent_JJ
          cells_NNS were_VBD dissolved_VBN in_IN Tris-buffered_NNP saline_NN (_( pH_NN 7_CD ._. 6_CD )_)
          containing_VBG 10_CD mM_NN EDTA_NNP and_CC 0_CD ._. 5_CD %_NN sarkosyl_NN ,_, and_CC 1_CD mg_NN /_NN ml_NN
          proteinase_NN K_NNP ._. After_IN digestion_NN (_( ~_NN 16_CD h_NN )_) of_IN cellular_JJ
          proteins_NNS at_IN 55_CD °_NN C_NNP ,_, DNA_NNP was_VBD sequentially_RB extracted_VBN with_IN
          phenol_NN /_NN chloroform_NN and_CC chloroform_NN ._. The_DT DNA_NNP was_VBD
          precipitated_VBD ,_, washed_VBN in_IN 70_CD %_NN ethanol_NN ,_, and_CC dissolved_VBN in_IN
          buffer_NN containing_VBG 10_CD mM_NN Tris-_NNP HCL_NNP (_( pH_NN 7_CD ._. 5_LS )_) and_CC 1_CD mM_NN EDTA_NNP ._.
          The_DT isolated_VBN DNA_NNP was_VBD treated_VBN with_IN RNase_NNP A_DT and_CC then_RB
          analyzed_VBN by_IN conventional_JJ agarose_NN gel_NN electrophoresis_NNS [_NN 41_CD
          ]_NN ._. DNA_NNP was_VBD visualized_JJ with_IN ultraviolet_NN light_JJ after_IN
          ethidium_NN bromide_NN staining_VBG ._.
        
        
          Caspase_NNP activity_NN assays_NNS
          Cells_NNP (_( 10_CD 6_CD per_IN 60_CD mm_NN dish_NN )_) were_VBD grown_VBN for_IN 16_CD h_NN ._. After_IN
          washing_VBG with_IN PBS_NNP ,_, the_DT cells_NNS were_VBD incubated_JJ with_IN 50_CD to_TO 100_CD
          μM_NN bile_NN acids_NNS for_IN 1_CD to_TO 2_CD h_NN ._. After_IN the_DT incubation_NN period_NN ,_,
          the_DT medium_NN was_VBD discarded_VBN and_CC adherent_NN cells_NNS were_VBD
          harvested_VBN in_IN PBS_NNP and_CC sedimented_JJ by_IN centrifugation_NN (_( 500_CD ×_NN
          g_SYM )_) ._. The_DT cells_NNS were_VBD resuspended_JJ in_IN buffer_NN containing_VBG 50_CD mM_NN
          Tris-_NNP HCl_NNP (_( pH_NN 7_CD ._. 5_LS )_) ,_, 1_CD %_NN Nonidet_NNP P-_NNP 40_CD ,_, and_CC 150_CD mM_NN NaCl_NNP ._.
          Following_VBG 10_CD min_NN incubation_NN on_IN ice_NN ,_, lysed_JJ cells_NNS were_VBD
          centrifuged_JJ for_IN 10_CD min_NN ,_, 10_CD ,_, 000_CD ×_NN g_SYM at_IN 4_CD °_NN C_NNP ._. The_DT
          supernatant_NN was_VBD assayed_JJ for_IN caspase_NN activity_NN in_IN 20_CD mM_NN
          Piperazine-_NNP N_NNP ,_, N_NNP '_POS -_: bis_NNS (_( 2_CD -_: ethanesulfonic_JJ acid_NN )_) (_( pH_NN 6_CD ._. 8_CD )_) ,_, 100_CD
          mM_NN NaCl_NNP ,_, 1_CD mM_NN EDTA_NNP ,_, 1_CD %_NN CHAPS_NNP ,_, and_CC 10_CD %_NN sucrose_NN with_IN
          Z-IETD-AFC_NNP for_IN caspase_NN 8_CD [_NN 42_CD 43_CD ]_NN ._. The_DT release_NN of_IN the_DT
          fluorogenic-leaving_JJ group_NN was_VBD detected_VBN by_IN excitation_NN at_IN
          400_CD nm_NN and_CC emission_NN at_IN 505_CD nm_NN ._. Free_NNP AFC_NNP was_VBD used_VBN to_TO
          generate_VB standard_JJ curve_NN ._.
        
        
          PI_NNP 3_CD K_NNP activity_NN assay_NN
          Crude_JJ membrane_NN fractions_NNS were_VBD isolated_VBN from_IN CHO_NNP ._. asbt_NN
          and_CC McNtcp_NNP ._. 24_CD cells_NNS as_IN described_VBN previously_RB [_NN 44_CD ]_NN ._. To_TO
          prepare_VB lipid_NN suspension_NN ,_, phosphatidylserine_NN and_CC
          phosphatidylinositol_NN (_( 1_CD :_: 1_LS )_) were_VBD sonicated_JJ in_IN 25_CD mM_NN
          3_CD -_: (_( N-_NNP morpholino_NN )_) propanesulfonic_JJ acid_NN (_( MOPS_NNP ;_: pH_NN 7_CD ._. 0_CD )_) ,_, 1_CD mM_NN
          EGTA_NNP ,_, 1_CD mM_NN Na_NNP 
          3_CD VO_NNP 
          4_CD ._. Cell_NNP extracts_NNS were_VBD assayed_JJ in_IN 25_CD
          mM_NN MOPS_NNP (_( pH_NN 7_CD ._. 5_LS )_) ,_, 5_CD mM_NN MgCl_NNP 
          2_CD ,_, 1_CD mM_NN EGTA_NNP ,_, 1_CD mM_NN Na_NNP 
          3_CD VO_NNP 
          4_CD ,_, 130_CD μM_NN ATP_NNP ,_, 20_CD μCi_NN [_NN 32_CD P_NN ]_NN -_: ATP_NNP
          (_( 3000_CD Ci_NNP /_NN mmol_NN )_) and_CC 0_CD ._. 2_CD mg_NN /_NN ml_NN sonicated_JJ lipids_NNS ._. The_DT
          reaction_NN was_VBD allowed_VBN to_TO proceed_VB for_IN 10_CD min_NN at_IN 37_CD °_NN C_NNP and_CC
          stopped_VBN by_IN addition_NN of_IN 300_CD μl_NN of_IN 1_CD N_NNP HCl_NNP :_: methanol_NN (_( 1_CD :_: 1_LS )_) ._.
          Lipids_NNP were_VBD extracted_VBN twice_RB with_IN 350_CD μl_NN chloroform_NN and_CC
          the_DT organic_JJ phases_NNS from_IN both_DT extractions_NNS were_VBD combined_VBN
          then_RB washed_VBN once_RB with_IN 700_CD μl_NN 1_CD N_NNP HCl_NNP /_NN methanol_NN (_( 1_CD :_: 1_LS )_) ._.
          Lipids_NNP were_VBD dried_VBN ,_, and_CC then_RB taken_VBN up_RP in_IN
          chloroform_NN :_: methanol_NN (_( 1_CD :_: 1_LS )_) ._. The_DT samples_NNS were_VBD spotted_VBN along_IN
          with_IN pure_JJ phosphoinositol_NN phosphate_NN standards_NNS (_( Avanti_NNP
          Polar_NNP Lipids_NNP ,_, Alabaster_NNP ,_, AL_NNP ,_, USA_NNP )_) onto_IN 1_CD ._. 2_CD %_NN potassium_NN
          oxalate_NN impregnated_JJ TLC_NNP plates_NNS [_NN 45_CD ]_NN ._. The_DT chromatogram_NN
          was_VBD developed_VBN in_IN chloroform_NN :_: methanol_NN :_: water_NN :_: aqueous_JJ
          ammonia_NN (_( 90_CD :_: 70_CD :_: 17_CD :_: 3_LS )_) [_NN 46_CD ]_NN ._. The_DT incorporation_NN of_IN [_NN 32_CD P_NN ]_NN
          into_IN phosphatidylinositol_NN was_VBD quantitated_JJ by_IN
          phosphorimaging_VBG using_VBG a_DT Fuji_NNP BAS_NNP 1000_CD phosphorimager_NN ._.
          Visualization_NNP of_IN standards_NNS was_VBD done_VBN by_IN dippingTLC_NN plates_NNS
          in_IN 10_CD %_NN CuSO_NNP 
          4_CD ,_, 10_CD %_NN H_NNP 
          3_CD PO_NNP 
          4_CD and_CC heating_NN at_IN 200_CD °_NN C_NNP for_IN 10_CD min_NN ._.
        
        
          Statistical_NNP analysis_NN
          Each_DT set_NN of_IN experiments_NNS was_VBD repeated_VBN at_IN least_JJS twice_RB ._.
          The_DT data_NNS is_VBZ represented_VBN by_IN means_VBZ ±_NN SD_NNP ._. Differences_NNS
          between_IN control_NN and_CC test_NN cells_NNS were_VBD evaluated_VBN by_IN a_DT
          Student_NNP 's_POS 
          t_NN test_NN ._. Differences_NNS in_IN the_DT slope_NN of_IN
          regression_NN lines_NNS were_VBD evaluated_VBN by_IN analysis_NN of_IN variance_NN ._.
          P_NN values_NNS of_IN <_NN 0_CD ._. 05_CD were_VBD considered_VBN statistically_RB
          significant_JJ ._.
        
      
      
        List_NN of_IN abbreviations_NNS used_VBN
        asbt_NN ,_, apical_JJ sodium_NN /_NN bile_NN acid_NN cotransporter_NN ;_: GCA_NNP ,_,
        glycocholic_JJ acid_NN ;_: GCDCA_NNP ,_, glycochenodeoxycholic_JJ acid_NN ;_: HBAB_NNP ,_,
        human_JJ bile_NN acid_NN binder_NN ;_: LDH_NNP ,_, lactate_NN dehydrogenase_NN ;_: PI_NNP 3_CD K_NNP ,_,
        phosphatidylinositol_NN 3_CD -_: kinase_NN ;_: TCA_NNP ,_, taurocholic_JJ acid_NN ,_,
        TCDCA_NNP ,_, taurochenodeoxycholic_JJ acid_NN
      
    
  
